PGK1 and breast carcinoma: In a study conducted by Sun et al., breast cancer patients undergoing Paclitaxel chemotherapy were analyzed, revealing that those with elevated PGK1 expression exhibited shorter overall survival compared to patients with lower PGK1 levels.